Approved Symbol
|
Approved Name
|
Location
|
No. of Studies (significant/non-significant/trend)
|
SLC6A3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
5p15.3 |
68(42/25/1)
|
DRD4 |
dopamine receptor D4 |
11p15.5 |
67(49/18/0)
|
COMT |
catechol-O-methyltransferase |
22q11.21 |
25(5/20/0)
|
SLC6A4 |
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
17q11.2 |
25(13/12/0)
|
DRD5 |
dopamine receptor D5 |
4p16.1 |
22(14/6/2)
|
DBH |
dopamine beta-hydroxylase (dopamine beta-monooxygenase) |
9q34 |
20(11/9/0)
|
MAOA |
monoamine oxidase A |
Xp11.4-p11.3 |
20(13/7/0)
|
SNAP25 |
synaptosomal-associated protein, 25kDa |
20p12-p11.2 |
18(13/5/0)
|
SLC6A2 |
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
16q12.2 |
16(10/5/1)
|
BDNF |
brain-derived neurotrophic factor |
11p14.1 |
14(8/6/0)
|
HTR1B |
5-hydroxytryptamine (serotonin) receptor 1B |
6q13 |
13(5/8/0)
|
ADRA2A |
adrenergic, alpha-2A-, receptor |
10q24-q26 |
12(4/8/0)
|
HTR2A |
5-hydroxytryptamine (serotonin) receptor 2A |
13q14-q21 |
12(6/6/0)
|
DRD2 |
dopamine receptor D2 |
11q22-q23 |
10(3/7/0)
|
TPH2 |
tryptophan hydroxylase 2 |
12q15 |
10(7/3/0)
|
DRD1 |
dopamine receptor D1 |
5q34-q35 |
8(5/3/0)
|
DRD3 |
dopamine receptor D3 |
3q13.3 |
8(1/7/0)
|
ADRA2C |
adrenergic, alpha-2C-, receptor |
4p16.3 |
7(2/4/1)
|
CHRNA4 |
cholinergic receptor, nicotinic, alpha 4 |
20 |
7(4/3/0)
|
TH |
tyrosine hydroxylase |
11p15.5 |
7(2/5/0)
|
DDC |
dopa decarboxylase (aromatic L-amino acid decarboxylase) |
7p11 |
6(5/1/0)
|
MAOB |
monoamine oxidase B |
Xp11.4-p11.3 |
6(2/4/0)
|
TPH1 |
tryptophan hydroxylase 1 |
11p15.3-p14 |
6(2/4/0)
|
HTR2C |
5-hydroxytryptamine (serotonin) receptor 2C |
Xq24 |
5(2/3/0)
|
LPHN3 |
latrophilin 3 |
4q13.1 |
4(3/0/1)
|
SYT1 |
synaptotagmin I |
12cen-q21 |
4(2/2/0)
|
FADS1 |
fatty acid desaturase 1 |
11q12-q13.1 |
3(1/2/0)
|
FADS2 |
fatty acid desaturase 2 |
11q12.2 |
3(3/0/0)
|
HTR3B |
5-hydroxytryptamine (serotonin) receptor 3B |
11q23.1 |
3(1/2/0)
|
CDH13 |
cadherin 13, H-cadherin (heart) |
16q23.3 |
3(1/1/1)
|
ADRA1A |
adrenergic, alpha-1A-, receptor |
8p21.2 |
3(2/1/0)
|
GRIN2A |
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
16p13.2 |
3(1/2/0)
|
NTF3 |
neurotrophin 3 |
12p13 |
3(1/2/0)
|
PNMT |
phenylethanolamine N-methyltransferase |
17q |
3(2/1/0)
|
STS |
steroid sulfatase (microsomal), isozyme S |
Xp22.32 |
3(2/1/0)
|
STX1A |
syntaxin 1A (brain) |
7q11.2 |
3(2/1/0)
|
SYP |
synaptophysin |
Xp11.23-p11.22 |
3(3/0/0)
|
GDNF |
glial cell derived neurotrophic factor |
5p13.1-p12 |
2(1/1/0)
|
CSNK1E |
casein kinase 1, epsilon |
22q13.1 |
2(1/1/0)
|
ELK3 |
ELK3, ETS-domain protein (SRF accessory protein 2) |
12q23 |
2(2/0/0)
|
SLC1A3 |
solute carrier family 1 (glial high affinity glutamate transporter), member 3 |
5p13 |
2(1/1/0)
|
HLA-DRB1 |
major histocompatibility complex, class II, DR beta 1 |
6p21.3 |
2(1/1/0)
|
ADRB1 |
adrenergic, beta-1-, receptor |
10q24-q26 |
2(0/2/0)
|
IL1RN |
interleukin 1 receptor antagonist |
2q14.2 |
2(1/1/0)
|
NR4A2 |
nuclear receptor subfamily 4, group A, member 2 |
2q22-q23 |
2(0/2/0)
|
ARRB1 |
arrestin, beta 1 |
11q13 |
2(1/1/0)
|
VAMP2 |
vesicle-associated membrane protein 2 (synaptobrevin 2) |
17pter-p12 |
2(0/2/0)
|
NFIL3 |
nuclear factor, interleukin 3 regulated |
9q22 |
2(1/1/0)
|
CALY |
calcyon neuron-specific vesicular protein |
10q26.3 |
2(1/1/0)
|
CPLX2 |
complexin 2 |
5q35.2 |
2(1/0/1)
|
CTNNA2 |
catenin (cadherin-associated protein), alpha 2 |
2p12-p11.1 |
2(1/1/0)
|
ASTN2 |
astrotactin 2 |
9q33 |
2(0/0/2)
|
ATP2C2 |
ATPase, Ca++ transporting, type 2C, member 2 |
16q24.1 |
2(0/1/1)
|
GRM5 |
glutamate receptor, metabotropic 5 |
11q14.3 |
2(1/0/1)
|
CHRNA7 |
cholinergic receptor, nicotinic, alpha 7 |
15q13.3 |
2(0/1/1)
|
ADRB2 |
adrenergic, beta-2-, receptor, surface |
5q31-q32 |
2(1/1/0)
|
ADRB3 |
adrenergic, beta-3-, receptor |
8p12 |
2(0/2/0)
|
CLOCK |
clock homolog (mouse) |
4q12 |
2(2/0/0)
|
EMP2 |
epithelial membrane protein 2 |
16p13.2 |
2(0/0/2)
|
GIT1 |
G protein-coupled receptor kinase interacting ArfGAP 1 |
17p11.2 |
2(1/1/0)
|
HTR1D |
5-hydroxytryptamine (serotonin) receptor 1D |
1p36.3-p34.3 |
2(1/1/0)
|
HTR1E |
5-hydroxytryptamine (serotonin) receptor 1E |
6q14-q15 |
2(2/0/0)
|
HTR6 |
5-hydroxytryptamine (serotonin) receptor 6 |
1p36-p35 |
2(0/2/0)
|
NGF |
nerve growth factor (beta polypeptide) |
1p13.1 |
2(2/0/0)
|
SLC18A2 |
solute carrier family 18 (vesicular monoamine), member 2 |
10q25 |
2(0/2/0)
|
SLC9A9 |
solute carrier family 9 (sodium/hydrogen exchanger), member 9 |
3q23-q24 |
2(2/0/0)
|
ADRA1B |
adrenergic, alpha-1B-, receptor |
5q33.3 |
2(1/1/0)
|
AANAT |
aralkylamine N-acetyltransferase |
17q25 |
1(0/0/1)
|
ADRBK2 |
adrenergic, beta, receptor kinase 2 |
22q11 |
1(0/1/0)
|
ASMT |
acetylserotonin O-methyltransferase |
Xp22.3 and Yp11.3 |
1(1/0/0)
|
ATP2B3 |
ATPase, Ca++ transporting, plasma membrane 3 |
Xq28 |
1(0/1/0)
|
GRIK4 |
glutamate receptor, ionotropic, kainate 4 |
11q |
1(0/1/0)
|
ATPBD4 |
ATP binding domain 4 |
15q14 |
1(0/0/1)
|
HTR3A |
5-hydroxytryptamine (serotonin) receptor 3A |
11q23.1-q23.2 |
1(0/1/0)
|
DACT1 |
dapper, antagonist of beta-catenin, homolog 1 (Xenopus laevis) |
14q22.3 |
1(0/1/0)
|
MAP2K3 |
mitogen-activated protein kinase kinase 3 |
17q11.2 |
1(0/1/0)
|
GNAO1 |
guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O |
16q13 |
1(0/1/0)
|
NADSYN1 |
NAD synthetase 1 |
11q13.4 |
1(0/0/1)
|
GNAT2 |
guanine nucleotide binding protein (G protein), alpha transducing activity polypeptide 2 |
1p13 |
1(1/0/0)
|
GNAZ |
guanine nucleotide binding protein (G protein), alpha z polypeptide |
22q11.1-q11.2 |
1(0/1/0)
|
CLASP2 |
cytoplasmic linker associated protein 2 |
3p24.3 |
1(0/0/1)
|
GPR125 |
G protein-coupled receptor 125 |
4p15.31 |
1(0/1/0)
|
CACNA1C |
calcium channel, voltage-dependent, L type, alpha 1C subunit |
12p13.3 |
1(0/1/0)
|
GPR50 |
G protein-coupled receptor 50 |
Xq28 |
1(0/0/1)
|
LPL |
lipoprotein lipase |
8p22 |
1(0/0/1)
|
GSK3B |
glycogen synthase kinase 3 beta |
3q13.3 |
1(1/0/0)
|
IL20RA |
interleukin 20 receptor, alpha |
6q23.3 |
1(0/0/1)
|
H2AFY |
H2A histone family, member Y |
5q31.1 |
1(0/1/0)
|
HTR4 |
5-hydroxytryptamine (serotonin) receptor 4 |
5q31-q33 |
1(1/0/0)
|
C21orf34 |
chromosome 21 open reading frame 34 |
21q11-q21.1 |
1(0/0/1)
|
HTR5A |
5-hydroxytryptamine (serotonin) receptor 5A |
7q36.1 |
1(0/1/0)
|
DMRT2 |
doublesex and mab-3 related transcription factor 2 |
9p24.3 |
1(0/0/1)
|
LMO4 |
LIM domain only 4 |
1p22.3 |
1(0/1/0)
|
FOXP1 |
forkhead box P1 |
3p14.1 |
1(0/0/1)
|
LOC100128765 |
similar to hCG2041516 [WITHDRAWN RefSeq, protein coding gene] |
13q12.11 |
1(0/0/1)
|
HAS3 |
hyaluronan synthase 3 |
16q22.1 |
1(0/0/1)
|
LOC643308 |
ribosomal protein L7 pseudogene [Inferred RefSeq, pseudo gene] |
7q35 |
1(0/0/1)
|
HTR1A |
5-hydroxytryptamine (serotonin) receptor 1A |
5q11.2-q13 |
1(1/0/0)
|
MOG |
myelin oligodendrocyte glycoprotein |
6p22-p21.3 |
1(0/1/0)
|
KANK2 |
KN motif and ankyrin repeat domains 2 |
19p13.2 |
1(0/1/0)
|
MTNR1A |
melatonin receptor 1A |
4q35 |
1(1/0/0)
|
MEIS2 |
Meis homeobox 2 |
15q14 |
1(0/0/1)
|
NPAS3 |
neuronal PAS domain protein 3 |
14q12-q13 |
1(1/0/0)
|
NEUROD6 |
neurogenic differentiation 6 |
7p15.1 |
1(0/1/0)
|
SH3BP5 |
SH3-domain binding protein 5 (BTK-associated) |
3p24.3 |
1(0/0/1)
|
NPPC |
natriuretic peptide C |
2q24-qter |
1(0/1/0)
|
TCEB1 |
transcription elongation factor B (SIII), polypeptide 1 (15kDa, elongin C) |
8q13.3 |
1(0/0/1)
|
UNC5B |
unc-5 homolog B (C. elegans) |
10q22.2 |
1(0/0/1)
|
PER1 |
period homolog 1 (Drosophila) |
17p13.1 |
1(0/1/0)
|
XPO1 |
exportin 1 (CRM1 homolog, yeast) |
2p15 |
1(0/0/1)
|
PGRMC2 |
progesterone receptor membrane component 2 |
4q26 |
1(0/1/0)
|
ZNF423 |
zinc finger protein 423 |
16q12 |
1(0/0/1)
|
PHLDA1 |
pleckstrin homology-like domain, family A, member 1 |
12q15 |
1(0/1/0)
|
CNTF |
ciliary neurotrophic factor |
11q12 |
1(1/0/0)
|
PRELID2 |
PRELI domain containing 2 |
5q32 |
1(0/1/0)
|
ADRBK1 |
adrenergic, beta, receptor kinase 1 |
11q13 |
1(0/1/0)
|
RGS18 |
regulator of G-protein signaling 18 |
1q31.2 |
1(0/1/0)
|
RPL23AP56 |
ribosomal protein L23a pseudogene 56 |
8q24.22 |
1(0/1/0)
|
CDK20 |
cyclin-dependent kinase 20 |
9q22.1 |
1(0/1/0)
|
SNCA |
synuclein, alpha (non A4 component of amyloid precursor) |
4q21.3-q22 |
1(0/1/0)
|
DNAJA1P4 |
DnaJ (Hsp40) homolog, subfamily A, member 1 pseudogene 4 |
6q22.1 |
1(0/1/0)
|
SORCS1 |
sortilin-related VPS10 domain containing receptor 1 |
10q23-q25 |
1(0/0/1)
|
ID2 |
inhibitor of DNA binding 2, dominant negative helix-loop-helix protein |
2p25 |
1(0/1/0)
|
SSFA2 |
sperm specific antigen 2 |
2q32.1 |
1(0/1/0)
|
LOC151121 |
uncharacterized [MODEL RefSeq, unknown gene] |
2q21.1 |
1(0/1/0)
|
TDO2 |
tryptophan 2,3-dioxygenase |
4q31-q32 |
1(1/0/0)
|
MMP7 |
matrix metallopeptidase 7 (matrilysin, uterine) |
11q21-q22 |
1(0/0/1)
|
MTNR1B |
melatonin receptor 1B |
11q21-q22 |
1(0/0/1)
|
VEGFA |
vascular endothelial growth factor A |
6p12 |
1(0/1/0)
|
CNTN4 |
contactin 4 |
3p26.3 |
1(1/0/0)
|
RPL31P43 |
ribosomal protein L31 pseudogene 43 |
9q31.2 |
1(0/1/0)
|
DCLK2 |
doublecortin-like kinase 2 |
4q31.3 |
1(0/0/1)
|
TAAR3 |
trace amine associated receptor 3 (gene/pseudogene) |
6q23-q24 |
1(0/1/0)
|
DPP6 |
dipeptidyl-peptidase 6 |
7q36.2 |
1(1/0/0)
|
GABRG1 |
gamma-aminobutyric acid (GABA) A receptor, gamma 1 |
4p12 |
1(0/0/1)
|
GRM1 |
glutamate receptor, metabotropic 1 |
6q24 |
1(1/0/0)
|
GRM7 |
glutamate receptor, metabotropic 7 |
3p26-p25 |
1(1/0/0)
|
GRM8 |
glutamate receptor, metabotropic 8 |
7q31.3-q32.1 |
1(1/0/0)
|
LARP7 |
La ribonucleoprotein domain family, member 7 |
4q25 |
1(1/0/0)
|
MACROD2 |
MACRO domain containing 2 |
20p12.1 |
1(0/0/1)
|
NEGR1 |
neuronal growth regulator 1 |
1p31.1 |
1(1/0/0)
|
NLN |
neurolysin (metallopeptidase M3 family) |
5q12.3 |
1(1/0/0)
|
PARK2 |
parkinson protein 2, E3 ubiquitin protein ligase (parkin) |
6q25.2-q27 |
1(1/0/0)
|
PTPRN2 |
protein tyrosine phosphatase, receptor type, N polypeptide 2 |
7q36 |
1(0/0/1)
|
SGTB |
small glutamine-rich tetratricopeptide repeat (TPR)-containing, beta |
5q12.3 |
1(1/0/0)
|
SLC7A10 |
solute carrier family 7, (neutral amino acid transporter, y+ system) member 10 |
19q13.1 |
1(1/0/0)
|
SORCS3 |
sortilin-related VPS10 domain containing receptor 3 |
10q23-q25 |
1(0/0/1)
|
USP24 |
ubiquitin specific peptidase 24 |
1p32.3 |
1(1/0/0)
|
ZBBX |
zinc finger, B-box domain containing |
3q26.1 |
1(0/0/1)
|
CLYBL |
citrate lyase beta like |
13q32.3 |
1(0/0/1)
|
ARVCF |
armadillo repeat gene deleted in velocardiofacial syndrome |
22q11.21 |
1(1/0/0)
|
HES1 |
hairy and enhancer of split 1, (Drosophila) |
3q28-q29 |
1(1/0/0)
|
MYO5B |
myosin VB |
18q |
1(0/1/0)
|
PRKG1 |
protein kinase, cGMP-dependent, type I |
10q11.2 |
1(0/0/1)
|
TCERG1L |
transcription elongation regulator 1-like |
10q26.3 |
1(0/0/1)
|
TRIM32 |
tripartite motif containing 32 |
9q33.1 |
1(0/0/1)
|
ATP11A |
ATPase, class VI, type 11A |
13q34 |
1(0/1/0)
|
CNTN5 |
contactin 5 |
11q21-q22.2 |
1(0/0/1)
|
ANO5 |
anoctamin 5 |
11p15.1 |
1(0/0/1)
|
DLEU2 |
deleted in lymphocytic leukemia 2 (non-protein coding) |
13q14 |
1(0/0/1)
|
EREG |
epiregulin |
4q21.21 |
1(0/0/1)
|
HES6 |
hairy and enhancer of split 6 (Drosophila) |
2q37.3 |
1(0/1/0)
|
OR4C3 |
olfactory receptor, family 4, subfamily C, member 3 |
11p11.2 |
1(0/0/1)
|
ADRA1D |
adrenergic, alpha-1D-, receptor |
20p13 |
1(0/1/0)
|
ADRA2B |
adrenergic, alpha-2B-, receptor |
2q11.1 |
1(1/0/0)
|
AGBL1 |
ATP/GTP binding protein-like 1 |
15q25.3 |
1(0/0/1)
|
AK094352 |
Homo sapiens cDNA FLJ37033 fis, clone BRACE2011389 |
15q26.1 |
1(0/0/1)
|
AK8 |
adenylate kinase 8 |
9q34.13 |
1(0/0/1)
|
ANK3 |
ankyrin 3, node of Ranvier (ankyrin G) |
10q21 |
1(0/1/0)
|
ARRB2 |
arrestin, beta 2 |
17p13 |
1(1/0/0)
|
ATXN1 |
ataxin 1 |
6p23 |
1(0/0/1)
|
ATXN2 |
ataxin 2 |
12q23-q24.1 |
1(0/0/1)
|
BAIAP2 |
BAI1-associated protein 2 |
17q25 |
1(1/0/0)
|
BCL11A |
B-cell CLL/lymphoma 11A (zinc finger protein) |
2p16.1 |
1(0/0/1)
|
BMPR1B |
bone morphogenetic protein receptor, type IB |
4q23-q24 |
1(0/0/1)
|
C1orf173 |
chromosome 1 open reading frame 173 |
1p31.1 |
1(0/1/0)
|
CAMK1D |
calcium/calmodulin-dependent protein kinase ID |
10p13 |
1(0/0/1)
|
CDH23 |
cadherin-related 23 |
10q22.1 |
1(0/1/0)
|
CEP112 |
centrosomal protein 112kDa |
17q24.2 |
1(0/0/1)
|
CHMP7 |
CHMP family, member 7 |
8p21.2 |
1(0/0/1)
|
CHRNA3 |
cholinergic receptor, nicotinic, alpha 3 |
15q24 |
1(0/1/0)
|
CMTM8 |
CKLF-like MARVEL transmembrane domain containing 8 |
3p22.2 |
1(1/0/0)
|
CNR1 |
cannabinoid receptor 1 (brain) |
6q14-q15 |
1(1/0/0)
|
CNTFR |
ciliary neurotrophic factor receptor |
9p13 |
1(1/0/0)
|
COX7B2 |
cytochrome c oxidase subunit VIIb2 |
4p12 |
1(0/1/0)
|
CPLX1 |
complexin 1 |
4p16.3 |
1(1/0/0)
|
CRYGC |
crystallin, gamma C |
2q33-q35 |
1(0/0/1)
|
CSMD2 |
CUB and Sushi multiple domains 2 |
1p34.3 |
1(0/0/1)
|
DCDC2 |
doublecortin domain containing 2 |
6p22.1 |
1(1/0/0)
|
DCLK1 |
doublecortin-like kinase 1 |
13q13.3 |
1(1/0/0)
|
DENND3 |
DENN/MADD domain containing 3 |
8q24.3 |
1(0/1/0)
|
DGKH |
diacylglycerol kinase, eta |
13q13.3 |
1(1/0/0)
|
DNM1 |
dynamin 1 |
9q34 |
1(0/0/1)
|
DOCK10 |
dedicator of cytokinesis 10 |
2q36.3 |
1(0/0/1)
|
DUSP1 |
dual specificity phosphatase 1 |
5q35.1 |
1(0/1/0)
|
DYX1C1 |
dyslexia susceptibility 1 candidate 1 |
15q21.1 |
1(0/1/0)
|
ELOVL6 |
ELOVL fatty acid elongase 6 |
4q25 |
1(0/0/1)
|
FAM190A |
family with sequence similarity 190, member A |
4q22.1 |
1(1/0/0)
|
FGF10 |
fibroblast growth factor 10 |
5p13-p12 |
1(0/1/0)
|
FHIT |
fragile histidine triad gene |
3p14.2 |
1(0/0/1)
|
FLNC |
filamin C, gamma |
7q32-q35 |
1(0/0/1)
|
FOXP2 |
forkhead box P2 |
7q31 |
1(1/0/0)
|
FURIN |
furin (paired basic amino acid cleaving enzyme) |
15q26.1 |
1(0/0/1)
|
GFI1B |
growth factor independent 1B transcription repressor |
9q34.13 |
1(0/1/0)
|
GFOD1 |
glucose-fructose oxidoreductase domain containing 1 |
6pter-p22.1 |
1(1/0/0)
|
GNAL |
guanine nucleotide binding protein (G protein), alpha activating activity polypeptide, olfactory type |
18p11.22-p11.21 |
1(1/0/0)
|
GPC5 |
glypican 5 |
13q32 |
1(0/0/1)
|
GPC6 |
glypican 6 |
13q32 |
1(0/0/1)
|
GPX6 |
glutathione peroxidase 6 (olfactory) |
6p22.1 |
1(0/1/0)
|
GRID2 |
glutamate receptor, ionotropic, delta 2 |
4q22 |
1(0/0/1)
|
GRIK1 |
glutamate receptor, ionotropic, kainate 1 |
21q22 |
1(0/0/1)
|
GRIN2B |
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
12p12 |
1(1/0/0)
|
HCN1 |
hyperpolarization activated cyclic nucleotide-gated potassium channel 1 |
5p12 |
1(0/1/0)
|
HK1 |
hexokinase 1 |
10q22 |
1(0/1/0)
|
HKDC1 |
hexokinase domain containing 1 |
10q22.1 |
1(0/1/0)
|
HOXB1 |
homeobox B1 |
17q21.32 |
1(0/0/1)
|
HTR1F |
5-hydroxytryptamine (serotonin) receptor 1F |
3p12 |
1(0/1/0)
|
HTR7 |
5-hydroxytryptamine (serotonin) receptor 7 (adenylate cyclase-coupled) |
10q21-q24 |
1(0/1/0)
|
IL16 |
interleukin 16 (lymphocyte chemoattractant factor) |
15q26.3 |
1(0/0/1)
|
ISL1 |
ISL LIM homeobox 1 |
5q11.2 |
1(0/1/0)
|
ITGA1 |
integrin, alpha 1 |
5q11.1 |
1(0/1/0)
|
ITGA11 |
integrin, alpha 11 |
15q22.3-q23 |
1(0/0/1)
|
ITGAE |
integrin, alpha E (antigen CD103, human mucosal lymphocyte antigen 1; alpha polypeptide) |
17p13 |
1(0/0/1)
|
KCNC1 |
potassium voltage-gated channel, Shaw-related subfamily, member 1 |
11p15 |
1(0/1/0)
|
KCNIP4 |
Kv channel interacting protein 4 |
4p15.32 |
1(1/0/0)
|
KIAA0319 |
KIAA0319 |
6p22.3-p22.2 |
1(0/1/0)
|
KIAA1267 |
KIAA1267 |
17q21.31 |
1(0/0/1)
|
LECT1 |
leukocyte cell derived chemotaxin 1 |
13q14.3 |
1(0/1/0)
|
LIN7C |
lin-7 homolog C (C. elegans) |
11p14 |
1(1/0/0)
|
LOC100188947 |
uncharacterized [VALIDATED RefSeq, miscRNA] |
10q23.32 |
1(1/0/0)
|
MAGI2 |
membrane associated guanylate kinase, WW and PDZ domain containing 2 |
7q21 |
1(0/0/1)
|
MAN2A2 |
mannosidase, alpha, class 2A, member 2 |
15q25 |
1(0/0/1)
|
MAP1B |
microtubule-associated protein 1B |
5q13 |
1(0/0/1)
|
MCTP1 |
multiple C2 domains, transmembrane 1 |
5q15 |
1(0/1/0)
|
MMP24 |
matrix metallopeptidase 24 (membrane-inserted) |
20q11.2 |
1(0/0/1)
|
MOBP |
myelin-associated oligodendrocyte basic protein |
3p21.33 |
1(0/0/1)
|
MTHFR |
methylenetetrahydrofolate reductase (NAD(P)H) |
1p36.3 |
1(0/1/0)
|
MYBPC1 |
myosin binding protein C, slow type |
12q32 |
1(0/1/0)
|
MYT1L |
myelin transcription factor 1-like |
2p25.3 |
1(0/0/1)
|
NAPRT1 |
nicotinate phosphoribosyltransferase domain containing 1 |
8q24.3 |
1(0/0/1)
|
NCKAP5 |
NCK-associated protein 5 |
2q21.2 |
1(0/0/1)
|
NOS1 |
nitric oxide synthase 1 (neuronal) |
12q14-qter |
1(1/0/0)
|
NPSR1 |
neuropeptide S receptor 1 |
7p14.3 |
1(0/1/0)
|
NR3C2 |
nuclear receptor subfamily 3, group C, member 2 |
4q31 |
1(0/1/0)
|
NRSN1 |
neurensin 1 |
6p22.1 |
1(1/0/0)
|
NRXN1 |
neurexin 1 |
2p16.3 |
1(0/1/0)
|
NT5DC3 |
5'-nucleotidase domain containing 3 |
12q22-q23.1 |
1(0/0/1)
|
NTRK2 |
neurotrophic tyrosine kinase, receptor, type 2 |
9q22.1 |
1(1/0/0)
|
NUCB1 |
nucleobindin 1 |
19q13.33 |
1(0/0/1)
|
NXPH1 |
neurexophilin 1 |
7p22 |
1(0/1/0)
|
OPRM1 |
opioid receptor, mu 1 |
6q24-q25 |
1(1/0/0)
|
OXER1 |
oxoeicosanoid (OXE) receptor 1 |
2p22.1 |
1(0/0/1)
|
OXTR |
oxytocin receptor |
3p25 |
1(0/1/0)
|
PCDP1 |
primary ciliary dyskinesia protein 1 [Validated RefSeq, protein coding gene] |
2q14.2 |
1(0/0/1)
|
PER2 |
period homolog 2 (Drosophila) |
2q37.3 |
1(1/0/0)
|
PEX5L |
peroxisomal biogenesis factor 5-like |
3q27.1 |
1(0/0/1)
|
PLCL1 |
phospholipase C-like 1 |
2q33 |
1(0/0/1)
|
PPM1F |
protein phosphatase, Mg2+/Mn2+ dependent, 1F |
22q11.22 |
1(0/0/1)
|
PPM1H |
protein phosphatase, Mg2+/Mn2+ dependent, 1H |
12q14.1 |
1(0/0/1)
|
PPP1R1B |
protein phosphatase 1, regulatory (inhibitor) subunit 1B |
17 |
1(0/1/0)
|
PPP2R2C |
protein phosphatase 2, regulatory subunit B, gamma |
4p16.1 |
1(1/0/0)
|
PRKAG2 |
protein kinase, AMP-activated, gamma 2 non-catalytic subunit |
7q35-q36 |
1(0/0/1)
|
PRTG |
protogenin |
15q21.3 |
1(1/0/0)
|
PSMC3 |
proteasome (prosome, macropain) 26S subunit, ATPase, 3 |
11p11.2 |
1(0/0/1)
|
PTPRG |
protein tyrosine phosphatase, receptor type, G |
3p21-p14 |
1(0/0/1)
|
PTPRJ |
protein tyrosine phosphatase, receptor type, J |
11p11.2 |
1(0/1/0)
|
RBMS3 |
RNA binding motif, single stranded interacting protein 3 |
3p24-p23 |
1(0/1/0)
|
REEP5 |
receptor accessory protein 5 |
5q22-q23 |
1(0/0/1)
|
SDK2 |
sidekick homolog 2 (chicken) |
17q21.31 |
1(0/1/0)
|
SLC39A3 |
solute carrier family 39 (zinc transporter), member 3 |
19p13.3 |
1(0/1/0)
|
SLC5A7 |
solute carrier family 5 (choline transporter), member 7 |
2q12 |
1(1/0/0)
|
SLC6A1 |
solute carrier family 6 (neurotransmitter transporter, GABA), member 1 |
3p25-p24 |
1(0/1/0)
|
SLCO3A1 |
solute carrier organic anion transporter family, member 3A1 |
15q26 |
1(0/0/1)
|
SLIT1 |
slit homolog 1 (Drosophila) |
10q23.3-q24 |
1(0/0/1)
|
SNPH |
syntaphilin |
20p13 |
1(1/0/0)
|
SRGAP1 |
SLIT-ROBO Rho GTPase activating protein 1 |
12q13.13 |
1(0/0/1)
|
SUPT3H |
suppressor of Ty 3 homolog (S. cerevisiae) |
6p21.1-p12.3 |
1(0/0/1)
|
SYN3 |
synapsin III |
22q12.3 |
1(0/1/0)
|
SYT2 |
synaptotagmin II |
1q32.1 |
1(1/0/0)
|
TDP2 |
tyrosyl-DNA phosphodiesterase 2 |
6p22.3-p22.1 |
1(0/1/0)
|
TFEB |
transcription factor EB |
6p21 |
1(0/0/1)
|
TIAM2 |
T-cell lymphoma invasion and metastasis 2 |
6q25 |
1(0/0/1)
|
TLL2 |
tolloid-like 2 |
10q23-q24 |
1(0/0/1)
|
TRIO |
triple functional domain (PTPRF interacting) |
5p14-p15.1 |
1(0/0/1)
|
TSPAN8 |
tetraspanin 8 |
12q14.1-q21.1 |
1(0/1/0)
|
UGT1A9 |
UDP glucuronosyltransferase 1 family, polypeptide A9 |
2q37 |
1(0/0/1)
|
WDR96 |
WD repeat domain 96 |
10q25.1 |
1(0/0/1)
|
XKR3 |
XK, Kell blood group complex subunit-related family, member 3 |
22q11.1 |
1(0/0/1)
|
XKR4 |
XK, Kell blood group complex subunit-related family, member 4 |
8q12.1 |
1(1/0/0)
|
ZNF544 |
zinc finger protein 544 |
19q13.43 |
1(0/0/1)
|
ZNF75A |
zinc finger protein 75a |
16p13.11 |
1(0/0/1)
|
ZNF804A |
zinc finger protein 804A |
2q32.1 |
1(0/1/0)
|
ZNF805 |
zinc finger protein 805 |
19q13.43 |
1(0/0/1)
|
CPLX4 |
complexin 4 |
18q21.32 |
1(1/0/0)
|
CREB5 |
cAMP responsive element binding protein 5 |
7p15 |
1(0/0/1)
|
DHCR7 |
7-dehydrocholesterol reductase |
11q13.4 |
1(0/0/1)
|
DIRAS2 |
DIRAS family, GTP-binding RAS-like 2 |
9q22.32 |
1(1/0/0)
|
NET1 |
neuroepithelial cell transforming 1 |
10p15 |
0
|